US has no specific prohibition on human germline editing and no real capacity for a regulatory framework.
Melanie Hess -2020 A Call for an International Governance Framework for Human Germline Gene Editing 95 Notre Dame Law Review 1369 https://scholarship.law.nd.edu/cgi/viewcontent.cgi?article=4899&context=ndlr
The United States does not have an explicit legal prohibition on human germline editing.78 This is relatively unusual in the international community, where there are official prohibitions on human germline editing in many countries, including ones that allow human embryonic stem cell research.79 That said, germline editing does not exactly have a clear path forward in the current U.S. regulatory and political climate. Current genome-editing protocols and clinical trials in the United States do not have their own regulatory framework and have instead been “absorbed into the preexisting U.S. regulatory framework for gene therapy, whose overview is largely derived from gene transfer studies”80—despite the fact that germline editing, while involving similar technologies and techniques, has vastly different consequences and implications